Industry: Chemical & Material
Published Date: 2026-06-05
Pages: 144 Pages
Report ld: 6048803
Request Sample
Customized Report
Glucose Dehydrogenase Market Size(US$)

CAGR 2026-2032
6.8%
Market Size,2032
USD 562
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Glucose Dehydrogenase market is projected to grow from US$ 358 million in 2025 to US$ 562 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Glucose dehydrogenase (GDH) is an oxidoreductase that catalyzes the oxidation of glucose to gluconolactone while reducing cofactors such as NAD⁺, PQQ, or FAD. It is widely used in blood glucose monitoring, biosensors, in vitro diagnostics (IVD), and biocatalysis. Depending on cofactors, GDH is classified into NAD-dependent, FAD-dependent, and PQQ-dependent types, with PQQ-GDH being widely used in continuous glucose monitoring (CGM) systems. In 2025, global sales volume of glucose dehydrogenase amounted to 341 tons, with an average selling price of $1,050 per Kg and an industry gross margin of 50%–75%. The glucose dehydrogenase industry chain consists of upstream raw materials and strain engineering, midstream enzyme manufacturing, and downstream applications. The upstream segment includes genetically engineered strains (e.g., E. coli, Bacillus subtilis), expression vectors, and fermentation media, with high technical barriers, especially for PQQ-GDH systems. The midstream involves enzyme production through fermentation, purification, lyophilization, and stabilization, representing the core value-added stage. Downstream applications include IVD (glucose test strips, CGM sensors), biosensors, food testing, and biocatalysis. With rising diabetes prevalence and CGM adoption, medical demand is rapidly increasing. The industry is also shifting toward higher stability, longer enzyme lifespan, and reduced interference, driving recombinant enzyme engineering as a key R&D direction.
Key market drivers for glucose dehydrogenase (GDH) include the growing global diabetic population, which continues to increase demand for glucose monitoring; rapid adoption of continuous glucose monitoring (CGM) systems, where GDH serves as a core biorecognition enzyme; rising penetration of point-of-care testing (POCT) devices in primary healthcare and homecare settings; advances in biotechnology that improve recombinant GDH production efficiency and reduce manufacturing costs; and expanding applications in food safety testing and industrial biocatalysis. In addition, high-stability technologies such as FAD-GDH are gradually replacing conventional glucose oxidase (GOx) systems in high-end diagnostics. Global aging trends and increasing chronic disease management demand are also strengthening the importance of GDH in healthcare diagnostics. On the risk side, GDH still faces competition from alternative enzyme technologies such as GOx, which retains cost advantages in some low-end applications. Technical barriers related to engineered strains, expression systems, and fermentation processes remain high, making market entry difficult for new players. Strict IVD and medical device regulations, especially in the US and European markets, may slow product approvals and commercialization. Fluctuations in fermentation media, purification materials, and bioprocessing costs can also affect profitability. In addition, the CGM market is highly concentrated, giving major downstream players strong bargaining power over upstream GDH suppliers. Diagnostic-grade GDH products also require extremely high stability, anti-interference capability, and batch consistency, increasing ongoing R&D and quality-control investment requirements.
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Glucose Dehydrogenase market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (capacity, sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Glucose Dehydrogenase study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue, sales, and production to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: Maps global production capacity, utilization, and market share (2021–2032), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks
Chapter 7: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 8: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 9: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 10: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 11: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth: details product specs, capacity, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 13: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles
Chapter 14: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 7-11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Glucose Dehydrogenase: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Glucose Dehydrogenase Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 NAD-dependent GDH
1.2.3 FAD-dependent GDH
1.2.4 PQQ-dependent GDH
1.3 Market Segmentation by Source
1.3.1 Global Glucose Dehydrogenase Market Size by Source, 2021 vs 2025 vs 2032
1.3.2 Microbial-derived
1.3.3 Recombinant Enzyme
1.3.4 Native Extraction
1.4 Market Segmentation by Form
1.4.1 Global Glucose Dehydrogenase Market Size by Form, 2021 vs 2025 vs 2032
1.4.2 Lyophilized Powder
1.4.3 Liquid Enzyme
1.4.4 Immobilized Enzyme
1.5 Market Segmentation by Application
1.5.1 Global Glucose Dehydrogenase Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Glucose Test Strips
1.5.3 Continuous Glucose Monitoring
1.5.4 IVD / POCT Testing
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Glucose Dehydrogenase Revenue Estimates and Forecasts (2021-2032)
2.2 Global Glucose Dehydrogenase Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Glucose Dehydrogenase Sales Estimates and Forecasts (2021-2032)
2.4 Global Glucose Dehydrogenase Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Global Sales Market Share by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.5 Global Glucose Dehydrogenase Production Capacity and Utilization (2021 vs 2025 vs 2032)
2.6 Production Comparison by Region: 2021 vs 2025 vs 2032
3 Competitive Landscape
3.1 Global Glucose Dehydrogenase Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Glucose Dehydrogenase Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 NAD-dependent GDH: Market Share by Key Manufacturers
3.5.2 FAD-dependent GDH: Market Share by Key Manufacturers
3.5.3 PQQ-dependent GDH: Market Share by Key Manufacturers
3.6 Global Glucose Dehydrogenase Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Market Entry and Exit Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Glucose Dehydrogenase Sales Performance by Type
4.1.1 Global Glucose Dehydrogenase Sales Volume by Type (2021-2032)
4.1.2 Global Glucose Dehydrogenase Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Glucose Dehydrogenase Sales Performance by Source
4.2.1 Global Glucose Dehydrogenase Sales Volume by Source (2021-2032)
4.2.2 Global Glucose Dehydrogenase Revenue by Source (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Source (2021-2032)
4.3 Global Glucose Dehydrogenase Sales Performance by Form
4.3.1 Global Glucose Dehydrogenase Sales Volume by Form (2021-2032)
4.3.2 Global Glucose Dehydrogenase Revenue by Form (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Form (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Glucose Dehydrogenase Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Glucose Dehydrogenase Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 Global Production Analysis
6.1 Global Glucose Dehydrogenase Production Capacity and Utilization Rates (2021–2032)
6.2 Regional Production Dynamics and Outlook
6.2.1 Historic Production by Region (2021-2026)
6.2.2 Forecasted Production by Region (2027-2032)
6.2.3 Production Market Share by Region (2021-2032)
6.2.4 Regulatory and Trade Policy Impact on Production
6.2.5 Production Capacity Enablers and Constraints
6.3 Key Regional Production Hubs
6.3.1 North America
6.3.2 Europe
6.3.3 Japan
6.3.4 Southeast Asia
6.3.5 India
6.3.6 China
7 North America
7.1 North America Sales Volume and Revenue (2021-2032)
7.2 North America Key Manufacturers Sales Revenue in 2025
7.3 North America Glucose Dehydrogenase Sales and Revenue by Application (2021-2032)
7.4 North America Growth Accelerators and Market Barriers
7.5 North America Glucose Dehydrogenase Market Size by Country
7.5.1 North America Revenue by Country
7.5.2 North America Sales Trends by Country
7.5.3 US
7.5.4 Canada
7.5.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2021-2032)
8.2 Europe Key Manufacturers Sales Revenue in 2025
8.3 Europe Glucose Dehydrogenase Sales and Revenue by Application (2021-2032)
8.4 Europe Growth Accelerators and Market Barriers
8.5 Europe Glucose Dehydrogenase Market Size by Country
8.5.1 Europe Revenue by Country
8.5.2 Europe Sales Trends by Country
8.5.3 Germany
8.5.4 France
8.5.5 U.K.
8.5.6 Italy
8.5.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
9.3 Asia-Pacific Glucose Dehydrogenase Sales and Revenue by Application (2021-2032)
9.4 Asia-Pacific Glucose Dehydrogenase Market Size by Region
9.4.1 Asia-Pacific Revenue by Region
9.4.2 Asia-Pacific Sales Trends by Region
9.5 Asia-Pacific Growth Accelerators and Market Barriers
9.6 Southeast Asia
9.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
9.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.7 China
9.8 Japan
9.9 South Korea
9.10 China Taiwan
9.11 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2021-2032)
10.2 Central and South America Key Manufacturers Sales Revenue in 2025
10.3 Central and South America Glucose Dehydrogenase Sales and Revenue by Application (2021-2032)
10.4 Central and South America Investment Opportunities and Key Challenges
10.5 Central and South America Glucose Dehydrogenase Market Size by Country
10.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 Brazil
10.5.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
11.3 Middle East and Africa Glucose Dehydrogenase Sales and Revenue by Application (2021-2032)
11.4 Middle East and Africa Investment Opportunities and Key Challenges
11.5 Middle East and Africa Glucose Dehydrogenase Market Size by Country
11.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
11.5.2 GCC Countries
11.5.3 Turkey
11.5.4 Egypt
11.5.5 South Africa
12 Corporate Profile
12.1 Sekisui Diagnostics
12.1.1 Sekisui Diagnostics Corporation Information
12.1.2 Sekisui Diagnostics Business Overview
12.1.3 Sekisui Diagnostics Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.1.4 Sekisui Diagnostics Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.1.5 Sekisui Diagnostics Glucose Dehydrogenase Sales by Product in 2025
12.1.6 Sekisui Diagnostics Glucose Dehydrogenase Sales by Application in 2025
12.1.7 Sekisui Diagnostics Glucose Dehydrogenase Sales by Geographic Area in 2025
12.1.8 Sekisui Diagnostics Glucose Dehydrogenase SWOT Analysis
12.1.9 Sekisui Diagnostics Recent Developments
12.2 Oriental Yeast
12.2.1 Oriental Yeast Corporation Information
12.2.2 Oriental Yeast Business Overview
12.2.3 Oriental Yeast Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.2.4 Oriental Yeast Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.2.5 Oriental Yeast Glucose Dehydrogenase Sales by Product in 2025
12.2.6 Oriental Yeast Glucose Dehydrogenase Sales by Application in 2025
12.2.7 Oriental Yeast Glucose Dehydrogenase Sales by Geographic Area in 2025
12.2.8 Oriental Yeast Glucose Dehydrogenase SWOT Analysis
12.2.9 Oriental Yeast Recent Developments
12.3 Codexis
12.3.1 Codexis Corporation Information
12.3.2 Codexis Business Overview
12.3.3 Codexis Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.3.4 Codexis Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.3.5 Codexis Glucose Dehydrogenase Sales by Product in 2025
12.3.6 Codexis Glucose Dehydrogenase Sales by Application in 2025
12.3.7 Codexis Glucose Dehydrogenase Sales by Geographic Area in 2025
12.3.8 Codexis Glucose Dehydrogenase SWOT Analysis
12.3.9 Codexis Recent Developments
12.4 BBI Solutions
12.4.1 BBI Solutions Corporation Information
12.4.2 BBI Solutions Business Overview
12.4.3 BBI Solutions Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.4.4 BBI Solutions Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.4.5 BBI Solutions Glucose Dehydrogenase Sales by Product in 2025
12.4.6 BBI Solutions Glucose Dehydrogenase Sales by Application in 2025
12.4.7 BBI Solutions Glucose Dehydrogenase Sales by Geographic Area in 2025
12.4.8 BBI Solutions Glucose Dehydrogenase SWOT Analysis
12.4.9 BBI Solutions Recent Developments
12.5 SyncoZymes
12.5.1 SyncoZymes Corporation Information
12.5.2 SyncoZymes Business Overview
12.5.3 SyncoZymes Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.5.4 SyncoZymes Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.5.5 SyncoZymes Glucose Dehydrogenase Sales by Product in 2025
12.5.6 SyncoZymes Glucose Dehydrogenase Sales by Application in 2025
12.5.7 SyncoZymes Glucose Dehydrogenase Sales by Geographic Area in 2025
12.5.8 SyncoZymes Glucose Dehydrogenase SWOT Analysis
12.5.9 SyncoZymes Recent Developments
12.6 Novozymes
12.6.1 Novozymes Corporation Information
12.6.2 Novozymes Business Overview
12.6.3 Novozymes Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.6.4 Novozymes Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.6.5 Novozymes Recent Developments
12.7 Johnson Matthey
12.7.1 Johnson Matthey Corporation Information
12.7.2 Johnson Matthey Business Overview
12.7.3 Johnson Matthey Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.7.4 Johnson Matthey Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.7.5 Johnson Matthey Recent Developments
12.8 Hzymes
12.8.1 Hzymes Corporation Information
12.8.2 Hzymes Business Overview
12.8.3 Hzymes Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.8.4 Hzymes Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.8.5 Hzymes Recent Developments
12.9 Gproan Biotech
12.9.1 Gproan Biotech Corporation Information
12.9.2 Gproan Biotech Business Overview
12.9.3 Gproan Biotech Glucose Dehydrogenase Product Models, Descriptions and Specifications
12.9.4 Gproan Biotech Glucose Dehydrogenase Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.9.5 Gproan Biotech Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Glucose Dehydrogenase Industry Chain
13.2 Glucose Dehydrogenase Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Glucose Dehydrogenase Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Glucose Dehydrogenase Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Glucose Dehydrogenase Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
14.4 Impact of U.S. Tariffs
15 Key Findings in the Global Glucose Dehydrogenase Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Glucose Dehydrogenase market size was US$ 358 million in 2025 and is forecast to reach a readjusted size of US$ 562 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published Date: 2026-06-05
Pages: 129
USD 4250.00
(Single User License)
The global market for Glucose Dehydrogenase was estimated to be worth US$ 358 million in 2025 and is projected to reach US$ 562 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-06-05
Pages: 135
USD 3950.00
(Single User License)
The global Glucose Dehydrogenase market was valued at US$ 358 million in 2025 and is anticipated to reach US$ 562 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-06-05
Pages: 133
USD 2900.00
(Single User License)
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 175
USD 4900.00
(Single User License)
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-16
Pages: 134
USD 3950.00
(Single User License)
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2025-06-16
Pages: 174
USD 4900.00
(Single User License)
The global Glucose Dehydrogenase market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-06-16
Pages: 108
USD 4250.00
(Single User License)
The global market for Glucose Dehydrogenase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-06-16
Pages: 114
USD 2900.00
(Single User License)
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 93
USD 3950.00
(Single User License)
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 101
USD 3950.00
(Single User License)
The global Glucose Dehydrogenase market size was US$ 358 million in 2025 and is forecast to reach a readjusted size of US$ 562 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-06-05
Pages: 129
The global market for Glucose Dehydrogenase was estimated to be worth US$ 358 million in 2025 and is projected to reach US$ 562 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-06-05
Pages: 135
The global Glucose Dehydrogenase market was valued at US$ 358 million in 2025 and is anticipated to reach US$ 562 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-06-05
Pages: 133
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 175
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-16
Pages: 134
The global Glucose Dehydrogenase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2025-06-16
Pages: 174
The global Glucose Dehydrogenase market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-06-16
Pages: 108
The global market for Glucose Dehydrogenase was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-06-16
Pages: 114
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 93
The global market for Glucose Dehydrogenase was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 101
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now